Generic
31 January 2018 | 0 Comments
Long-term exposure to cannabis smoke is not associated with adverse effects on pulmonary function, according to clinical data published in the journal Chronic Obstructive Pulmonary Diseases. A team of investigators led by researchers at the Colorado School of Public Health assessed the relationship between marijuana use and respiratory function and symptoms in a cohort of […]
Tagged in BMI
Generic
31 January 2018 | 0 Comments
On Sunday, January 21st & Monday the 22nd, NORML members along with non-member cannabis-reform-supporters gathered at the general assembly in Virginia for a Lobby Day. I [Nicole] was among the participants in this specific effort to advocate for marijuana legislative reform. Having lived in Virginia my whole life and being a current constituent of Representative […]
Tagged in David Marsden, Jenn Michelle Pedini, Nicole Powell, NORML
Generic
30 January 2018 | 0 Comments
The individual most responsible for the medical marijuana movement in CA, and eventually in more than 30 states across this country, was San Francisco gay rights and marijuana advocate Dennis Peron, who died this past weekend from lung cancer at age 71. Peron was drafted and sent to Vietnam in 1966, where he first discovered […]
Tagged in CA, Dennis Peron, HIV, San Francisco
Generic
26 January 2018 | 0 Comments
On Wednesday, January 24th, fifty-four members of Congress representing both political parties sent a letter to President Trump denouncing the recent rescinding of the Cole Memo by Attorney General Jeff Sessions. Led by Senator Elizabeth Warren on the Senate side and Representative Jared Polis in the House, the signers stated: “These new policies have helped eliminate the […]
Tagged in Attorney General Sessions, Cole Memo, Donald Trump, President Trump
Did you know that?
25 January 2018 | 0 Comments
As marijuana legalization gains momentum in the United States, researchers worry about keeping the public safe, particularly on the roads. Recent studies have identified new biomarkers that can be used to estimate a person’s recent cannabinoid intake. But, using those markers to judge cognitive and behavioral impairment is complex, say toxicologists.
Tagged in United States